{
    "2018-03-05": [
        [
            {
                "time": "",
                "original_text": "医药界的“华为”A股上市提速 冲击医药股市值第一",
                "features": {
                    "keywords": [
                        "医药",
                        "华为",
                        "A股",
                        "上市",
                        "市值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：业绩披露期 建议关注业绩反转低估值优质标的",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "周报",
                        "业绩",
                        "披露",
                        "反转",
                        "低估值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "聚焦两会｜恒瑞医药孙飘扬：两会提了这些建议——",
                "features": {
                    "keywords": [
                        "两会",
                        "恒瑞医药",
                        "建议"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "晚间研报精选：机构重点关注意成股份等5股",
                "features": {
                    "keywords": [
                        "研报",
                        "机构",
                        "捷成股份"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "其他"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业卓越推：华兰生物(002007)",
                "features": {
                    "keywords": [
                        "医药",
                        "华兰生物",
                        "卓越"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药行业周报：聚焦子行业龙头 看好恒瑞医药、安科生物、美年健康等",
                "features": {
                    "keywords": [
                        "医药",
                        "周报",
                        "恒瑞医药",
                        "安科生物",
                        "美年健康"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：无论大小 增速和未来为王",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "周报",
                        "增速",
                        "未来"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "委员众议打造医药强国：医药创新的春天来了",
                "features": {
                    "keywords": [
                        "医药",
                        "创新",
                        "春天",
                        "强国"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业投资策略：年报密集期 精选业绩预期强烈估值合理的细分龙头",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "年报",
                        "业绩",
                        "估值",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业2018年3月份投资月报：创新药2.0+细分市场龙头",
                "features": {
                    "keywords": [
                        "医药",
                        "创新药",
                        "细分市场",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}